期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 110, 期 32, 页码 12984-12989出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1304045110
关键词
drug design; hot spots; protein-ligand interactions
资金
- Bill & Melinda Gates Foundation
- UK Biotechnology and Biological Sciences Research Council [BB/D006104/1]
- Fundacao para a Ciencia e Tecnologia
- Homerton College
- Biotechnology and Biological Sciences Research Council [BB/D006104/1] Funding Source: researchfish
- BBSRC [BB/D006104/1] Funding Source: UKRI
In fragment-based drug discovery, the weak affinities exhibited by fragments pose significant challenges for screening. Biophysical techniques are used to address this challenge, but there is no clear consensus on which cascade of methods is best suited to identify fragment hits that ultimately translate into bound X-ray structures and provide bona fide starting points for synthesis. We have benchmarked an integrated biophysical approach for fragment screening and validation against Mycobacterium tuberculosis pantothenate synthetase. A primary screen of 1,250 fragments library was performed by thermal shift, followed by secondary screen using one-dimensional NMR spectroscopy (water ligand observed gradient spectroscopy and saturation transfer difference binding experiments) and ultimate hit validation by isothermal titration calorimetry and X-ray crystallography. Our multibiophysical approach identified three distinct binding sites for fragments and laid a solid foundation for successful structure-based elaboration into potent inhibitors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据